Trial reportStroke2025
Effect of Perforator Territory Infarction on Functional Outcome in Patients With Large Vessel Occlusion.
Trial report in Stroke, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKnowledge of the anatomic distribution of cerebral perforating arteries and the consequences of ischemia in these territories is limited. This study aims to evaluate the effect of perforator territory ischemia on functional outcome in patients with anterior circulation large vessel occlusion.
methodsA post hoc analysis of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands, MR CLEAN-MED (Safety and Efficacy of Aspirin, Unfractionated Heparin, Both, or Neither During Endovascular Stroke Treatment) and MR CLEAN-NO IV (Intravenous Treatment Followed by Intra-Arterial Treatment Versus Direct Intra-Arterial Treatment for Acute Ischemic Stroke Caused by a Proximal Intracranial Occlusion) participants, recruited between January 2018 and January 2021 from 20 European stroke centers, was performed. Patients undergoing endovascular thrombectomy for anterior circulation large vessel occlusion with available posttreatment magnetic resonance imaging were included. Patients were assigned to 3 groups based on infarct location identified on ≤24 hours posttreatment magnetic resonance imaging: cortex group, perforator and insular group, and both groups (cortical alongside insular and perforator territory). Multivariable linear and ordinal regression analyses were performed separately with the National Institutes of Health Stroke Scale score at 24 hours as the primary outcome and modified Rankin Scale at 90 days as the secondary outcome, adjusted for baseline scores and prognostic factors.
resultsOut of 1167 patients, a total of 397 were included. The median age was 71 (interquartile range, 62-79), and 204 (51%) were men. Although no significant association was found in multivariable analysis between perforator territory infarctions and 24 hours National Institutes of Health Stroke Scale, patients with perforator territory ischemia were more likely to have a worse 90-days modified Rankin Scale (median modified Rankin Scale, 2 [interquartile range, 1-3]; common odds ratio, 2.94 [95% CI, 1.73-4.98]). Besides infarct locations, Thrombolysis in Cerebral Infarction grade 2B-3 and Heidelberg bleeding classifications 1c and 2 significantly influenced the 24-hour National Institutes of Health Stroke Scale and 90-day modified Rankin Scale outcomes.
conclusionsPatients with anterior circulation large vessel occlusion leading to perforator territory infarctions are more likely to have an unfavorable functional outcome at 90 days. Future research should focus on better visualization of perforating arteries and understanding their functional anatomy to prevent perforator territory ischemia and improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.